• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why VYNE Therapeutics Shares Are Trading Higher By 82%; Here Are 20 Stocks Moving Premarket

    1/10/23 7:55:17 AM ET
    $APGN
    $ARBK
    $ASTR
    $BBBY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $APGN alert in real time by email

    Gainers

    • VYNE Therapeutics Inc. (NASDAQ:VYNE) rose 82.2% to $0.35 in pre-market trading after the company said first vitiligo patient was dosed in Phase 1a/b clinical trial of novel BET inhibitor VYN201.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares rose 45.4% to $0.1178 in pre-market trading after gaining 4% on Monday.
    • Sotera Health Company (NASDAQ:SHC) rose 42.7% to $12.33 in pre-market trading after the company reported settlement of ethylene oxide litigation in Illinois.
    • Oak Street Health, Inc. (NYSE:OSH) shares rose 33.1% to $30.04 in pre-market trading. CVS Health Corp is in talks to buy Oak Street Health, Bloomberg News reported.
    • Versus Systems Inc. (NASDAQ:VS) rose 32.7% to $0.8039 in pre-market trading after jumping over 16% on Monday.
    • Nuwellis, Inc. (NASDAQ:NUWE) rose 23.4% to $11.50 in pre-market trading after gaining 11% on Monday. Nuwellis indicated that preliminary unaudited revenue for the fourth quarter and full year 2022 is anticipated to be approximately $2.3 million and $8.5 million, respectively, which shows an increase of 42% and 8% over the same periods last year.
    • Frontline plc (NYSE:FRO) rose 19.5% to $13.54 in pre-market trading. Frontline announced termination of combination agreement with Euronav.
    • Comstock Inc. (NYSE:LODE) shares rose 14.5% to $0.4607 in pre-market trading.
    • Swvl Holdings Corp. (NASDAQ:SWVL) rose 14.3% to $0.3006 in pre-market trading after dropping 12% on Monday. Swvl recently announced the commencement of a strategic review process.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 11.1% to $1.80 in pre-market trading after surging around 24% on Monday. The company is scheduled to release quarterly earnings today.


    Losers

    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) fell 20.7% to $1.53 in pre-market trading. Virgin Orbit shared its readiness for the Start Me Up mission for a historic U.K. launch on January 9.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) fell 17.3% to $3.64 in pre-market trading after jumping 42% on Monday.
    • Euronav NV (NYSE:EURN) shares fell 17.1% to $13.21 in pre-market trading.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) fell 13.6% to $0.57 in pre-market. Calithera Biosciences shares dipped around 82% on Monday after its board of directors determined to dissolve the company and liquidate its assets. Also, the company will discontinue all clinical development programs and reduce its workforce.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) fell 12.9% to $4.85 in pre-market trading after jumping around 22% on Friday.
    • Bitfarms Ltd. (NASDAQ:BITF) fell 12.4% to $0.5872 in pre-market trading after jumping 23% on Monday.
    • Apexigen, Inc. (NASDAQ:APGN) fell 11.1% to $1.60 in pre-market trading after gaining around 91% on Monday.
    • Freight Technologies, Inc. (NASDAQ:FRGT) fell 8.5% to $0.2201 in pre-market trading. The company expects 2023 revenue to be between $36 million and $42 million.
    • Argo Blockchain plc (NASDAQ:ARBK) fell 8.5% to $1.30 in pre-market trading.
    • Astra Space, Inc. (NASDAQ:ASTR) shares fell 8.4% to $0.4157 in pre-market trading.
    Get the next $APGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APGN
    $ARBK
    $ASTR
    $BBBY

    CompanyDatePrice TargetRatingAnalyst
    Bitfarms Ltd.
    $BITF
    1/27/2026$3.00Outperform → Mkt Perform
    Keefe Bruyette
    Frontline Plc
    $FRO
    1/12/2026Neutral → Buy
    Clarksons Platou
    Sotera Health Company
    $SHC
    1/9/2026$24.00Neutral → Overweight
    Piper Sandler
    Sotera Health Company
    $SHC
    1/9/2026$24.00Outperform
    RBC Capital Mkts
    Sotera Health Company
    $SHC
    12/18/2025Outperform
    William Blair
    Sotera Health Company
    $SHC
    11/13/2025$19.00Outperform
    BMO Capital Markets
    Comstock Inc.
    $LODE
    11/4/2025Market Perform → Outperform
    Noble Capital Markets
    Bitfarms Ltd.
    $BITF
    9/15/2025Buy
    Compass Point
    More analyst ratings

    $APGN
    $ARBK
    $ASTR
    $BBBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Farha Dany

    3 - Swvl Holdings Corp (0001875609) (Issuer)

    3/24/26 2:39:00 PM ET
    $SWVL
    Real Estate

    SEC Form 3 filed by new insider Krause Kenneth D.

    3 - Sotera Health Co (0001822479) (Issuer)

    3/20/26 4:53:14 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 3 filed by new insider Freudenthaler Paul D

    3 - Freight Technologies, Inc. (0001687542) (Issuer)

    3/19/26 6:43:56 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    $APGN
    $ARBK
    $ASTR
    $BBBY
    SEC Filings

    View All

    SEC Form 20-F filed by Frontline Plc

    20-F - Frontline plc (0000913290) (Filer)

    3/27/26 5:12:30 PM ET
    $FRO
    Marine Transportation
    Consumer Discretionary

    Nuwellis Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Nuwellis, Inc. (0001506492) (Filer)

    3/27/26 4:55:30 PM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Sotera Health Company

    SCHEDULE 13G/A - Sotera Health Co (0001822479) (Subject)

    3/27/26 1:15:44 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    $APGN
    $ARBK
    $ASTR
    $BBBY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Comstock Inc. Announces 2026 Annual Meeting

    VIRGINIA CITY, Nev., March 26, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE:LODE) ("Comstock" and the "Company") is pleased to announce that its 2026 Annual Meeting of Shareholders has been scheduled for Thursday, May 28, 2026, starting at 9:00 a.m. Pacific Daylight Time in Reno, Nevada, at the Peppermill Hotel. The meeting will feature Comstock Metals, strategic investments, and clean energy systems. The 2026 Annual Meeting schedule for May 28, 2026, is as follows:  8:00 am to 9:00 am PDT Continental Breakfast   9:00 am to 11:30 am PDT 2026 Annual Shareholders Meeting, Company Presentations, Q & A   12:00 pm to 1:00 pm PDT Lunch and Conversations with Company Management and Directors   

    3/26/26 6:15:00 AM ET
    $LODE
    Major Chemicals
    Industrials

    Comstock to Participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026

    VIRGINIA CITY, Nev., March 25, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE:LODE) ("Comstock" and the "Company") today announced that it will participate in a webcast presentation at the Lytham Partners 2026 Industrials & Basic Materials Investor Summit, taking place virtually on Wednesday, April 1, 2026. The webcast will take place at 10:00 a.m. ET on Wednesday, April 1, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/ibmsummit26/ or directly at https://lythampartners.com/ibmsummit26/lode/. A replay will also be available through the same links. About Comstock Inc. Comstock Inc. (NYSE:LODE) innovates and commercializes technologies,

    3/25/26 6:15:00 AM ET
    $LODE
    Major Chemicals
    Industrials

    Comstock Announces Full Year 2025 Achievements and Results

    VIRGINIA CITY, Nev., March 24, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE:LODE) ("Comstock," "our" and the "Company"), today announced its full year 2025 results, 2025 summary achievements, and our 2026 business outlook. "Last year marked a number of critical achievements that punctuated the turnaround from a junior mining opportunity into a validated, leading metals recovery company positioned for global growth, including final proof of our zero-landfill recycling concept from our demonstration facility, team-building, full permitting, final, first-of-its-kind engineered and tested designs, secured industrial scale facility and storage capacity and fully funded the facility and operati

    3/24/26 4:05:00 PM ET
    $LODE
    Major Chemicals
    Industrials

    $APGN
    $ARBK
    $ASTR
    $BBBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bitfarms downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded Bitfarms from Outperform to Mkt Perform and set a new price target of $3.00

    1/27/26 8:40:33 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    Frontline upgraded by Clarksons Platou

    Clarksons Platou upgraded Frontline from Neutral to Buy

    1/12/26 7:47:46 AM ET
    $FRO
    Marine Transportation
    Consumer Discretionary

    Sotera Health upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Sotera Health from Neutral to Overweight and set a new price target of $24.00

    1/9/26 8:33:00 AM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    $APGN
    $ARBK
    $ASTR
    $BBBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tabacco Joseph J Jr bought $102,200 worth of shares (20,000 units at $5.11) (SEC Form 4)

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 8:32:43 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chief Financial Officer Quinby Donald bought $10,400 worth of Ordinary Shares (4,000 units at $2.60) (SEC Form 4)

    4 - Freight Technologies, Inc. (0001687542) (Issuer)

    6/10/25 5:27:05 PM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    Director Lepore Patrick G bought $43,800 worth of shares (15,000 units at $2.92), increasing direct ownership by 41% to 51,472 units (SEC Form 4)

    4 - VYNE Therapeutics Inc. (0001566044) (Issuer)

    1/16/25 6:06:19 PM ET
    $VYNE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APGN
    $ARBK
    $ASTR
    $BBBY
    Leadership Updates

    Live Leadership Updates

    View All

    Comstock Inc. Appoints Three New Independent Directors as Company Accelerates Growth in Solar Recycling and Critical Metals Recovery

    VIRGINIA CITY, Nev., March 24, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE:LODE) ("Comstock" or the "Company"), a leader in converting under-utilized natural resources into renewable energy products and the only certified, zero-landfill solar recycling solution in North America, today announced the appointment of Donald A. Colvin, Steven Y. Pei and Robert M. Spence as independent directors to the Company's Board of Directors, effective immediately. Mr. Colvin will serve on the Company's Audit and Finance Committee once necessary approvals have been obtained, bringing world-class financial oversight credentials and direct solar sector board leadership experience to that role. Walter "Del"

    3/24/26 4:05:00 PM ET
    $LODE
    Major Chemicals
    Industrials

    Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

    MINNEAPOLIS, March 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Stuart L. Goldstein, MD, FASN as Director of Clinical Strategy. Dr. Goldstein is internationally recognized as a pioneer in pediatric nephrology and critical care medicine. He serves as Director of the Center for Acute Care Nephrology, holds the Clark D. West Endowed Chair in Pediatric Nephrology at Cincinnati Children's Hospital Medical Center and is Professor of Pediatrics at the University of Cincinnati College of Medicine. His work has helped define the modern understand

    3/5/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors

    MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of David A. McDonald and Martin J. Emerson to its Board of Directors, effective February 24, 2026. The appointments strengthen the Company's board with complementary expertise in public company leadership, capital markets, and medical device commercialization. "These appointments reflect our continued focus on operational discipline and long-term value creation," said John Erb, President and CEO of Nuwellis. "Marty has led multiple medical device organizations through scali

    2/26/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $APGN
    $ARBK
    $ASTR
    $BBBY
    Financials

    Live finance-specific insights

    View All

    Comstock Announces Full Year 2025 Achievements and Results

    VIRGINIA CITY, Nev., March 24, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE:LODE) ("Comstock," "our" and the "Company"), today announced its full year 2025 results, 2025 summary achievements, and our 2026 business outlook. "Last year marked a number of critical achievements that punctuated the turnaround from a junior mining opportunity into a validated, leading metals recovery company positioned for global growth, including final proof of our zero-landfill recycling concept from our demonstration facility, team-building, full permitting, final, first-of-its-kind engineered and tested designs, secured industrial scale facility and storage capacity and fully funded the facility and operati

    3/24/26 4:05:00 PM ET
    $LODE
    Major Chemicals
    Industrials

    Bitfarms Schedules Fourth Quarter 2025 Conference Call on March 31, 2026

    TORONTO, Ontario and NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX:BITF) ("Bitfarms" or the "Company"), a North American digital infrastructure and energy company, will report its fourth quarter 2025 financial results on Tuesday, March 31st before the market opens. Management will host a conference call on the same day at 8:00 am EST. All Q4 2025 materials will be available before the call and can be accessed on the ‘Financial Results' section of the Bitfarms investor site. The live webcast and a webcast replay of the conference call can be accessed here. To access the call by telephone, register here to receive dial-in numbers and a unique PIN to join the call.

    3/17/26 7:05:00 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Recent Highlights: Fourth quarter revenue of $2.4 million, a 4% increase compared to the prior-year quarter and 9% increase sequentially.208% increase in U.S. console sales in Q4 versus prior year quarter.Heart Failure revenue increased 48% and Pediatrics increased 16% year-over-year in Q4.Gross margin of 68.2% in Q4, compared to 58.4% in the prior-year quarter.Closed a $5.0 million private p

    3/10/26 8:15:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $APGN
    $ARBK
    $ASTR
    $BBBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Versus Systems Inc.

    SC 13G/A - Versus Systems Inc. (0001701963) (Subject)

    11/14/24 7:30:32 PM ET
    $VS
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Sotera Health Company

    SC 13G/A - Sotera Health Co (0001822479) (Subject)

    11/14/24 4:51:55 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sotera Health Company

    SC 13G/A - Sotera Health Co (0001822479) (Subject)

    11/14/24 4:50:09 PM ET
    $SHC
    Misc Health and Biotechnology Services
    Health Care